Intervention Review

You have free access to this content

Mycophenolate mofetil for relapsing-remitting multiple sclerosis

  1. Yousheng Xiao1,
  2. Jianyi Huang1,
  3. Hongye Luo2,
  4. Jin Wang1,*

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 7 FEB 2014

Assessed as up-to-date: 20 JAN 2013

DOI: 10.1002/14651858.CD010242.pub2


How to Cite

Xiao Y, Huang J, Luo H, Wang J. Mycophenolate mofetil for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010242. DOI: 10.1002/14651858.CD010242.pub2.

Author Information

  1. 1

    The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China

  2. 2

    Guangxi Medical University, Department of Epidemiology & Statistics, Nanning, Guangxi, China

*Jin Wang, Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, No. 22, Shuang Yong Lu, Nanning, Guangxi, 530021, China. wangjin72@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 FEB 2014

SEARCH

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 3]
Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.